U.S. Residential REITs Stock News

AECOM walked into this earnings season wearing the label of an underappreciated infrastructure play with solid long term growth credentials. Today the market slammed the stock anyway. The share price dropped 8.5% to about $67 after the company reported a quarterly loss and booked a heavy $337m pretax charge on a troubled construction management project. For investors, the headline is simple. AECOM just posted a sharp earnings hit driven by one project, while still pointing to record backlog...

Quanterix stock jumped about 8% to US$2.63 after earnings, a sharp move for a company that came into this week with double digit declines over the past month. The market is reacting to a very different story compared with the old high growth diagnostics promise. The headline this quarter is margin and cash discipline. Quanterix posted Q2 revenue of US$32.9 million while reporting a sizeable net loss and cutting full year revenue guidance to a range of US$142 million to US$148 million. The...

Sohu.com stock slipped 1.3% to US$14.24 after the Q2 print, a modest pullback for a company that has been quietly grinding out a 10.9% gain over the past month. The headline is not about a revenue surge. It is about a profit picture that looks fragile once you strip out tax noise. Management reported Q2 2026 net income from continuing operations of US$0.2m, helped by roughly US$30m of tax benefits that turned what would likely have been a red quarter into a slim profit. That gap between thin...

Cardinal Health entered this earnings week on a strong run, with the stock already up over the past quarter and edging another 1.3% higher to about US$240 by the close. The market reaction was positive but restrained for a distributor that just printed adjusted free cash flow of US$5.0b and full year revenue of US$254b. That gap between a modest price move and very large cash generation is the real story for you as a shareholder. Is Cardinal Health a rare case where a rich P/E and heavy debt...

Motorcar Parts of America walked into this earnings season with a stock that had drifted down in recent weeks and then barely budged on the print, closing up just 0.2% at US$12.45. That muted move masks a jarring headline. The company swung from a recent quarterly profit to a loss of US$13.4m in Q1 on revenue of US$168.0m. For an auto parts supplier that many investors view as a recovery and margin story, this quarter puts the squeeze in full view. The rest of the year now has to answer...

Northern Oil and Gas, Inc. recently reported second-quarter 2026 results, with revenue of US$745.24 million and net income of US$236.63 million, alongside unaudited production of 145,659 Boe per day and reaffirmed full-year 2026 production guidance and a US$0.45 per-share dividend. While six-month results showed lower revenue of US$750.26 million and a loss of US$286.22 million, the sharp quarterly earnings improvement and increased natural gas output give investors a more nuanced view of...

Oil prices remain sensitive to events in the Middle East, which keeps inflation expectations and defense priorities in focus for governments that rely on energy imports. That backdrop draws attention to companies in the Aerospace and Defense screener, which sit close to major spending decisions. For investors who do not want to sit on the sidelines, this article highlights 3 stocks from the screener that may warrant closer examination. The 3 Aerospace and Defense stocks below are just a...

Accendra Health stock closed at US$1.26, down 10% on the day, as investors reacted to another quarter in the red. The headline is not the revenue line. The real story is the squeeze in profitability, with Q2 basic earnings per share at a loss of US$1.16 and net income excluding extra items also in loss territory. For a home based health provider already dealing with high volatility and balance sheet pressure, that profit strain matters more than the single-day move. The key question now is...

Park Hotels & Resorts Inc. recently reported past second-quarter 2026 results, with revenue of US$680 million and net income of US$47 million, marking a move from a loss to profit year over year. Over the first half of 2026, the company maintained flat revenue of US$1.30 billions while turning a prior net loss into US$58 million of net income, and affirmed a quarterly dividend of US$0.25 per share payable in October 2026. With this swing to profitability now on the books, we’ll explore how...

AirSculpt Technologies just jumped 16.9% to about US$3.22, even though this stock has spent the past three months grinding lower. The spark was not a clean return to profits. It was a margin story in a turnaround quarter. Q2 revenue landed at US$42.9 million, while adjusted earnings before interest, tax, depreciation and amortization came in at US$4.9 million with gross margin around 61%. For a business still posting losses, that level of gross profitability is what the market latched onto...

Green Plains (GPRE) has turned profitable in both the second quarter and first half of 2026, even as sales and ethanol output were lower than a year earlier. See our latest analysis for Green Plains. Green Plains' recent earnings turnaround has arrived during a mixed price period, with the share price at US$15.56 after a 1-day share price return of 3.11%, a 7-day share price return down 8.63%, and a year to date share price return of 51.36%. Over a longer horizon, the stock shows a 1-year...

IDEXX Laboratories (NasdaqGS:IDXX) has launched the Catalyst proBNP Test, the first dual-species point-of-care NT-proBNP cardiac assay for companion animals. The new test enables real-time cardiac assessment for both dogs and cats at veterinary clinics. The Catalyst proBNP Test expands IDEXX Laboratories' in-clinic diagnostic menu for cardiac disease in pets. This move into real-time cardiac diagnostics at the clinic level fits into a broader shift toward data driven tools in animal and...

Fluent came into this earnings print as a high risk, low multiple ad tech stock that had quietly rallied over the past quarter. The stock slipped 3.5% to US$4.12 after the release, even though Q2 showed Commerce Media Solutions revenue of US$30.5 million and a return to year over year growth for the overall business. Losses persisted, with basic earnings per share still in the red. This keeps the focus squarely on whether this new commerce media mix can carry Fluent closer to sustainable...

Helios Technologies stock barely flinched after earnings, easing about 0.6% to roughly US$81, even though the quarter delivered one of the cleanest margin stories investors have seen from this company in years. That muted move hides a sharp reset in the quality of the earnings stream. The headline is margin power. Adjusted EBITDA margin sat just above 21% in Q2 while basic earnings per share reached about US$0.66. Alongside net debt at roughly 1.4 times adjusted EBITDA, Helios Technologies...

CECO Environmental stock jumped about 5% today to US$73.97, even though the headline earnings number showed a loss for the quarter. The market is reacting to something bigger than a single reported earnings per share figure. The key story is the margin picture. CECO Environmental reported record quarterly revenue of US$284.961m and adjusted earnings before interest, tax, depreciation and amortisation margins in the mid teens for the first time. That appears to have helped pull the stock out...

With the Strait of Hormuz back in the headlines and Brent crude at $88.91 a barrel, energy risk is once again front and center for global markets. Sudden supply scares can reshuffle where money flows in the oil and gas space, creating both potential openings and traps. This article explains how the latest flashpoint could matter for your portfolio and profiles 3 large oil and gas producers that are closely exposed to this news. The three producers that follow are just a starting sample, and...

Esquire Financial Holdings stock added 3% today to close at US$132.92. Yet the real story sits in the earnings tape. Q2 delivered US$1.60 in adjusted earnings per share and a return on equity above 18%. The market seemed to cheer another clean quarter from a premium valued bank without fully wrestling with what that combination of strong profitability and a higher P/E multiple now implies. Love Esquire Financial Holdings' 18% plus return on equity but wondering how its premium P/E stacks up...

Why Custom Truck One Source stock is back on investors’ radar Custom Truck One Source (CTOS) is drawing attention after reporting a return to profitability in the second quarter of 2026, alongside raised full year guidance and continued strength in transmission and distribution demand. See our latest analysis for Custom Truck One Source. Custom Truck One Source’s share price has eased slightly in the past week, yet the 90 day share price return of 7.26% and year to date share price return of...

N-able stock slipped 1.9% to US$3.15 into the close, which is a muted reaction to an earnings print that puts sentiment, not the income statement, in the spotlight. The headline is simple: solid recurring revenue and margin metrics met a sharply lower full year growth guide as management reset expectations around a go to market transition and renewal pressure in key security tools. For you as an investor, the emotional tug of a low share price sits against a software business posting about...

The market clipped Axsome Therapeutics by 2.3% today, even though the story on the income statement is far from simple. Axsome came into this earnings print after a choppy three months for the stock and reported US$218.4m in Q2 revenue, led by fast building neurology brands. The company still posted a quarterly net loss of US$51.3m, which keeps nerves high around profitability. For investors, the question is whether today’s modest share price pullback is sensible caution about ongoing losses...

Why Masco’s Latest Earnings Are Back in Focus Masco (MAS) is back on investor radar after its latest quarterly earnings showed higher net income and earnings per share compared with a year ago, even as sales edged lower. The company also issued full-year earnings guidance that outlined expected net income per share between $4.21 and $4.41. This new range has given investors clearer visibility on what management currently projects for 2026. See our latest analysis for Masco. At a share price...

Riot Platforms stock climbed 4.3% today to US$20.24, even though the headline story is still deep red ink. The company reported a Q2 net loss of US$237.2 million on revenue of US$174.2 million, as heavy non cash charges from Bitcoin holdings and data center build outs continued to bite. Traders focused on the near term beat of expectations around the new artificial intelligence data center leases. Long term investors will be more focused on the implications of this loss profile and the...

Amazon Pharmacy launches a program to offer Eli Lilly (NYSE: LLY) weight-loss drug Zepbound to eligible Medicare patients for US$50 per month using a new federal Medicare bridge initiative. The program automates eligibility checks and prior authorizations and offers home delivery or in-store pickup through participating pharmacies. Amazon Pharmacy also includes other obesity treatments in the US$50 Medicare offering, broadening access for patients on fixed incomes. Investors tracking Eli...

Consolidated Water stock jumped 6.9% to US$32.32 heading into the first trading session after its Q2 report, a strong move for a regulated utility. That pop looks tied to one thing more than any headline EPS line. The company delivered Q2 revenue of US$32.9m while gross margin compressed to 33%, yet the market appeared to focus on the earnings resilience rather than the squeeze. For investors, today is a sentiment stress test. Price is behaving as if this was a clean beat, while the...